89-110-968

APOE, Mouse, Clone: WUE-4, Abnova™

Manufacturer: Abnova Corporation

Select a Size

Pack Size SKU Availability Price
Each of 1 89-110-968-Each-of-1 In Stock ₹ 1,04,842.00

89-110-968 - Each of 1

₹ 1,04,842.00

In Stock

Quantity

1

Base Price: ₹ 1,04,842.00

GST (18%): ₹ 18,871.56

Total Price: ₹ 1,23,713.56

Antigen

APOE

Classification

Monoclonal

Conjugate

Unconjugated

Dilution

Western Blot (2 ug/mL) Immunohistochemistry (2 ug/mL) The optimal working dilution should be determined by the end user.

Gene

APOE

Gene Symbols

APOE

Immunogen

Human APOE.

Regulatory Status

RUO

Gene ID (Entrez)

348

Content And Storage

Store at 4°C for short term. For long term storage store at -20°C.Aliquot to avoid repeated freezing and thawing.

Isotype

IgG1 κ

Applications

ELISA, Immunohistochemistry, Western Blot

Clone

WUE-4

Description

Mouse monoclonal antibody raised against APOE.

Formulation

In Tris-glycine, 150mM NaCl (0.05% sodium azide)

Gene Alias

AD2/LPG/MGC1571/apoprotein

Host Species

Mouse

Quantity

100 μL

Primary or Secondary

Primary

Target Species

Human

Form

Liquid

Related Products

Img

Abnova Corporation

89-110-253

--

Img

Abnova Corporation

89-110-168

--

Img

Abnova Corporation

89-111-117

--

Img

Abnova Corporation

89-136-265

--

Img

Abnova Corporation

89-110-189

--

Img

Abnova Corporation

89-110-933

--

Img

Abnova Corporation

89-110-170

--

Img

Abnova Corporation

89-110-264

--

Description

  • Chylomicron remnants and very low density lipoprotein (VLDL) remnants are rapidly removed from the circulation by receptor-mediated endocytosis in the liver
  • Apolipoprotein E, a main apoprotein of the chylomicron, binds to a specific receptor on liver cells and peripheral cells
  • ApoE is essential for the normal catabolism of triglyceride-rich lipoprotein constituents
  • The APOE gene is mapped to chromosome 19 in a cluster with APOC1 and APOC2
  • Defects in apolipoprotein E result in familial dysbetalipoproteinemia, or type III hyperlipoproteinemia (HLP III), in which increased plasma cholesterol and triglycerides are the consequence of impaired clearance of chylomicron and VLDL remnants
  • [provided by RefSeq